Novi Health provides a clinical‑grade whole‑genome sequencing service using a mailed cheek‑swab kit, delivering pathogenic variant identification, polygenic risk scores, and pharmacogenomic insights through a secure, HIPAA‑compliant portal. Certified genetic counselors and board‑certified specialists interpret results and create personalized prevention plans, while automated reminders schedule evidence‑based screenings and connect users to in‑network providers. The platform also supplies de‑identified risk analytics for employer wellness programs to inform benefit design and reduce overall healthcare costs.
Funding
Funding not disclosed
Founders
Product
Problem
Many adults remain unaware of inherited disease risks because traditional genetic testing is costly, requires in‑person phlebotomy, and lacks integrated follow‑up care. Low screening rates lead to delayed diagnosis of cancers and cardiovascular conditions, driving higher treatment expenses and poorer outcomes.
Solution
Novi Health delivers a clinical‑grade whole‑genome sequencing panel that can be completed with a simple cheek swab, eliminating the need for venous draws. The raw sequencing data are processed through a validated bioinformatics pipeline that identifies pathogenic variants, calculates polygenic risk scores, and flags pharmacogenomic liabilities. Results are presented in a secure, HIPAA‑compliant portal together with a personalized risk‑stratification report. Certified genetic counselors and board‑certified medical specialists provide one‑on‑one interpretation sessions and actionable prevention plans. An automated reminder system schedules evidence‑based screening appointments and connects members with in‑network providers. For employer groups, the platform aggregates de‑identified risk metrics to inform benefit design and reduce overall healthcare spend.
Target Audience
The primary users are health‑conscious individuals seeking proactive disease prevention, and corporate wellness or benefits programs that aim to lower employee healthcare costs through genomics‑driven risk management.
Features
- Clinical‑grade whole‑genome sequencing performed on a mailed cheek‑swab kit with prepaid return shipping
- Proprietary variant‑calling and annotation pipeline delivering ACMG‑compliant pathogenicity classifications and polygenic risk scores
- Secure web portal with encrypted data storage, role‑based access, and real‑time result delivery
- Integrated genetic counseling via video or phone, plus expert medical opinion from specialty physicians
- Automated, risk‑based screening reminders and referral routing to qualified in‑network clinicians
- API‑enabled data exchange for employer health‑benefit platforms, supporting de‑identified analytics and reporting
- Ongoing prevention support team that provides longitudinal guidance and updates as new evidence emerges